Is ruxolitinib cream effective in treating vitiligo?

Ruxolitinib cream has significant efficacy in treating vitiligo. Ruxolitinib cream, as a topical JAK inhibitor, has shown significant efficacy in the treatment of vitiligo in recent years.

According to news released by Incyte, ruxolitinib cream met the primary endpoints in two pivotal 3 clinical trials (TRuE-V1 and TRuE-V2). A higher proportion of patients treated with ruxolitinib cream achieved at least a 75% improvement from baseline in their F-VASI score, a quantitative measure of vitiligo skin symptoms, at week 24. This data was significantly better than the placebo group, demonstrating the effectiveness of ruxolitinib cream in the treatment of vitiligo.

Ruxolitinib cream can help restore skin color in patients with vitiligo by stimulating melanocyte regeneration and pigmentation. This is of great significance for improving patients' quality of life.

Although ruxolitinib cream has shown significant efficacy in treating vitiligo, patients also need to be aware of its possible side effects. Common side effects include sore throat and diarrhea. In addition, topical ruxolitinib cream may cause adverse reactions such as acne, itching, and erythema. Therefore, you should pay close attention to the recovery of your skin during use and adjust your medication as directed by your doctor.

Ruxolitinib cream is suitable for adolescents and adult vitiligo patients 12 years old and above. Treatment with this drug is generally not recommended for infants or children with atopic dermatitis to avoid excessive irritation of the skin.